David T. Rodgers

1.6k total citations
21 papers, 1.3k citations indexed

About

David T. Rodgers is a scholar working on Oncology, Immunology and Parasitology. According to data from OpenAlex, David T. Rodgers has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 6 papers in Parasitology. Recurrent topics in David T. Rodgers's work include CAR-T cell therapy research (8 papers), Parasites and Host Interactions (6 papers) and Research on Leishmaniasis Studies (5 papers). David T. Rodgers is often cited by papers focused on CAR-T cell therapy research (8 papers), Parasites and Host Interactions (6 papers) and Research on Leishmaniasis Studies (5 papers). David T. Rodgers collaborates with scholars based in United Kingdom, United States and South Korea. David T. Rodgers's co-authors include Travis S. Young, William Harnett, Margaret M. Harnett, Peter G. Schultz, Miguel A. Pineda, Lamyaa Al‐Riyami, Chan Hyuk Kim, Eric Hampton, Timothy M. Wright and Yu Cao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

David T. Rodgers

21 papers receiving 1.3k citations

Peers

David T. Rodgers

ONCOL

IMMUN

GENET

Ashley K. Woods United States

Maya Ilouze Israel

Adriaan D. Bins Netherlands

Scott Roberts United States

Robert K. Bright United States

William Wan United States

Joyce Chen United States

Allan Jensen United States

Rob Woestenenk Netherlands

Cedric Mpoy United States

Ashley K. Woods United States

David T. Rodgers

412 ×0.5

ONCOL

237 ×0.5

338 ×0.8

200 ×0.6

IMMUN

116 ×0.5

GENET

Citations per year, relative to David T. Rodgers David T. Rodgers (= 1×) peers Ashley K. Woods

Countries citing papers authored by David T. Rodgers

Since Specialization

Citations

This map shows the geographic impact of David T. Rodgers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Rodgers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Rodgers more than expected).

Fields of papers citing papers by David T. Rodgers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Rodgers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Rodgers. The network helps show where David T. Rodgers may publish in the future.

Co-authorship network of co-authors of David T. Rodgers

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Rodgers. A scholar is included among the top collaborators of David T. Rodgers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Rodgers. David T. Rodgers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rodgers, David T., Tatiana I. Novobrantseva, & Rita N. Bárcia. (2024). Smart Cell Therapy: an industry perspective on macrophages as living drugs. Cytotherapy. 27(7). 849–863. 1 indexed citations

Raj, Deepak B. Thimiri Govinda, Ming-Hsin Yang, David T. Rodgers, et al.. (2018). Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma. Gut. 68(6). 1052–1064. 116 indexed citations

Yu, Shan, Reyna K. V. Lim, David T. Rodgers, et al.. (2017). P-262 A PDE4 Inhibitor-antibody Conjugate for Treating Ulcerative Colitis. Inflammatory Bowel Diseases. 23. 1 indexed citations

Mazagova, Magdalena, Sida Shao, Xinxin Wang, et al.. (2017). Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia. International Journal of Molecular Sciences. 18(11). 2259–2259. 58 indexed citations

Cao, Yu, David T. Rodgers, Juanjuan Du, et al.. (2016). Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer. Angewandte Chemie International Edition. 55(26). 7520–7524. 103 indexed citations

Marshall, Fraser A., David T. Rodgers, Miguel A. Pineda, et al.. (2016). The helminth product, ES-62 modulates dendritic cell responses by inducing the selective autophagolysosomal degradation of TLR-transducers, as exemplified by PKCδ. Scientific Reports. 6(1). 37276–37276. 20 indexed citations

Rodgers, David T., et al.. (2016). The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma. Scientific Reports. 6(1). 19224–19224. 29 indexed citations

Rodgers, David T., Magdalena Mazagova, Eric Hampton, et al.. (2016). Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies. Proceedings of the National Academy of Sciences. 113(4). E459–68. 317 indexed citations

Jennifer, S. Y., Stephanie A. Kazane, Seihyun Choi, et al.. (2016). Versatile strategy for controlling the specificity and activity of engineered T cells. Proceedings of the National Academy of Sciences. 113(4). E450–8. 237 indexed citations

10.

Yu, Shan, Reyna K. V. Lim, David T. Rodgers, et al.. (2016). Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody–drug Conjugate. Molecular Therapy. 24(12). 2078–2089. 41 indexed citations

11.

Cao, Yu, David T. Rodgers, Juanjuan Du, et al.. (2016). Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer. Angewandte Chemie. 128(26). 7646–7650. 8 indexed citations

12.

Rzepecka, Justyna, David T. Rodgers, James Doonan, et al.. (2016). Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES‐62 against clinically relevant allergens. Parasite Immunology. 38(6). 340–351. 6 indexed citations

13.

Rzepecka, Justyna, Miguel A. Pineda, Lamyaa Al‐Riyami, et al.. (2015). Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome. Journal of Autoimmunity. 60. 59–73. 69 indexed citations

14.

Al‐Riyami, Lamyaa, David T. Rodgers, Justyna Rzepecka, et al.. (2015). Protective effect of small molecule analogues of the Acanthocheilonema viteae secreted product ES-62 on oxazolone-induced ear inflammation. Experimental Parasitology. 158. 18–22. 9 indexed citations

15.

Rodgers, David T., Miguel A. Pineda, Colin J. Suckling, William Harnett, & Margaret M. Harnett. (2015). Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus. Lupus. 24(13). 1437–1442. 22 indexed citations

16.

Rodgers, David T., Mairi McGrath, Miguel A. Pineda, et al.. (2014). The Parasitic Worm Product ES‐62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice. Arthritis & Rheumatology. 67(4). 1023–1035. 45 indexed citations

17.

Pineda, Miguel A., David T. Rodgers, Lamyaa Al‐Riyami, William Harnett, & Margaret M. Harnett. (2014). ES‐62 Protects Against Collagen‐Induced Arthritis by Resetting Interleukin‐22 Toward Resolution of Inflammation in the Joints. Arthritis & Rheumatology. 66(6). 1492–1503. 48 indexed citations

18.

Al‐Riyami, Lamyaa, Miguel A. Pineda, Justyna Rzepecka, et al.. (2013). Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis. Journal of Medicinal Chemistry. 56(24). 9982–10002. 78 indexed citations

19.

Rodgers, David T., Miguel A. Pineda, Mairi McGrath, et al.. (2013). Protection against collagen‐induced arthritis in mice afforded by the parasitic worm product, ES‐62, is associated with restoration of the levels of interleukin‐10‐producing B cells and reduced plasma cell infiltration of the joints. Immunology. 141(3). 457–466. 44 indexed citations

20.

Knouse, Stephen B. & David T. Rodgers. (1981). An Analysis of the Resident-Assistant Position Based on the Behaviorally Anchored Rating-Scales Technique.. Journal of College Student Personnel. 22(5). 396–400. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact